Lupin launches generic pneumonia drug in US

New Delhi: Drug firm Lupin said Monday it has launched the generic Atovaquone oral suspension, which is used for the prevention and treatment of pneumonia, in the US market. The company has launched its Atovaquone oral suspension USP, 750 mg/5 ml, having received an approval from the United States Food and Drug Administration (USFDA) earlier, Lupin said in a filing to BSE.

The company’s product is the generic version of Glaxosmithkline LLC’s Mepron oral suspension in the same strength, it added.

As per IQVIA MAT September 2018 data, Atovaquone oral suspension USP, 750 mg/5 ml had annual sales of around USD 119 million in the US, Lupin said.

The product is indicated for the prevention of pneumocystis jirovecii pneumonia (PCP) in adults and adolescents aged 13 years and older who cannot tolerate trimethoprim/sulfamethoxazole.

It is also for the treatment of mild-to-moderate PCP in adults and adolescents aged 13 years and older who cannot tolerate trimethoprim/sulfamethoxazole, it added.

Shares of Lupin Ltd Monday closed at Rs 860.50 on BSE, up 0.74 per cent from the previous close.

  • Related Posts

    Piyush Goyal meets pharma industry leaders to discuss R&D, competitiveness boost

    New Delhi: Union Commerce and Industry Minister Piyush Goyal has discussed strategies to boost competitiveness and strengthen research and development activities with the business representatives of the pharmaceutical industry. “Had…

    Senores Pharma to Buy Two Teva ANDAs

    Mumbai, August 14, 2025 — Senores Pharmaceuticals will acquire two abbreviated new drug applications (ANDAs) from Teva Pharmaceuticals USA. The deal is Senores’ third US move in six months, underscoring…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Piyush Goyal meets pharma industry leaders to discuss R&D, competitiveness boost

    Piyush Goyal meets pharma industry leaders to discuss R&D, competitiveness boost

    Senores Pharma to Buy Two Teva ANDAs

    Senores Pharma to Buy Two Teva ANDAs

    Lab-grown rabies antibodies show promise as cheaper, safer alternative

    Lab-grown rabies antibodies show promise as cheaper, safer alternative

    Lilly launches Mounjaro KwikPen in India

    Lilly launches Mounjaro KwikPen in India